The present invention relates to the heart failure for the treatment of mammal.Therefore, the present invention is for setting up dosage, it is maintained and/or enhancing passes through the therapeutic benefit for applying neuregulin (such as glial growth factor 2 (GGF2) or its subsequence) imparting, and concomitantly minimizes any potential side effect.